Sommaire

• • ·Table of Contents

    Page :A3

    
• • ·Editorial Board

    Page :A9

    
• • ·Information for Authors

    Page :A10

    
• • ·Information for Authors

    Page :A11

    
• • ·Information for Readers

    Page :A12

    
• • ·Author Index

    Page :1334-1357

    
• • ·Subject Index

    Page :1358-1384

    

• Curriculum in Cardiology

  • ·Argatroban: Update

    Page :1131-1138

    Robert W. Yeh, Ik-Kyung Jang

    Résumé Résumé Plan Plan  
  • ·Coronary artery calcium scanning: Clinical paradigms for cardiac risk assessment and treatment

    Page :1139-1146

    Harvey S. Hecht, Matthew J. Budoff, Daniel S. Berman, James Ehrlich, John A. Rumberger

    Résumé Résumé Plan Plan  
  • ·Cardiovascular disease in HIV infection

    Page :1147-1155

    Isabella Sudano, Lukas E. Spieker, Georg Noll, Roberto Corti, Rainer Weber, Thomas F. Lüscher

    Résumé Résumé Plan Plan  

• Highlights of Expert Meetings

  • ·Highlights from the 55th Annual Scientific Sessions of the American College of Cardiology: March 11 to 14, 2006, Atlanta, Georgia

    Page :1156-1172

    Abhinav Goyal, James S. Mills, Pierluigi Tricoci, Kevin L. Thomas, Ricardo Baeza, George L. Adams, Chiara Melloni

    

• Trial Design

  • ·Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial : Veterans Affairs Cooperative Studies Program no. 424

    Page :1173-1179

    William E. Boden, Robert A. O'Rourke, Koon K. Teo, Pamela M. Hartigan, David J. Maron, William Kostuk, Merril Knudtson, Marcin Dada, Paul Casperson, Crystal L. Harris, John A. Spertus, Leslee Shaw, Bernard R. Chaitman, G.B. John Mancini, Daniel S. Berman, William S. Weintraub, On behalf of the COURAGE trial coprincipal investigators and study coordinators

    Résumé Résumé Plan Plan
  • ·Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial

    Page :1180-1185

    William S. Weintraub, Paul Barnett, Shuo Chen, Pamela Hartigan, Paul Casperson, Robert O'Rourke, William E. Boden, Cheryl Lewis, Emir Veledar, Edmund Becker, Steven Culler, Paul Kolm, Elizabeth M. Mahoney, Sandra B. Dunbar, Christi Deaton, Bernard O'Brien, Ron Goeree, Gordon Blackhouse, Robert Nease, John Spertus, Stan Kaufman, Koon Teo

    Résumé Résumé Plan Plan
  • ·Evaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non–ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial

    Page :1186.e1

    David A. Morrow, Benjamin M. Scirica, Ewa Karwatowska-Prokopczuk, Allan Skene, Carolyn H. McCabe, Eugene Braunwald, for the MERLIN-TIMI 36 Investigators

    Résumé Résumé Plan Plan  
  • ·The Second Prevention of Syncope Trial (POST II)—a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: Rationale and study design

    Page :1186.e11

    Satish R. Raj, Sarah Rose, Deborah Ritchie, Robert S. Sheldon, on behalf of the POST II Investigators 1

    Résumé Résumé Plan Plan  
  • ·Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events

    Page :1187-1193

    ACTIVE investigators

    Résumé Résumé Plan Plan  
  • ·The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phase

    Page :1194-1204

    Andrew T.L. Ong, Patrick W. Serruys, Frederick W. Mohr, Marie-Claude Morice, A. Pieter Kappetein, David R. Holmes, Michael J. Mack, Marcel van den Brand, Marie-Angele Morel, Gerrit-Anne van Es, Jeroen Kleijne, Joerg Koglin, Mary E. Russell

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·The influence of risk status on guideline adherence for patients with non–ST-segment elevation acute coronary syndromes

    Page :1205-1213

    Matthew T. Roe, Eric D. Peterson, L. Kristin Newby, Anita Y. Chen, Charles V. Pollack, Ralph G. Brindis, Robert A. Harrington, Robert H. Christenson, Sidney C. Smith, Robert M. Califf, Eugene Braunwald, W. Brian Gibler, E. Magnus Ohman

    Résumé Résumé Plan Plan  
  • ·The impact of platelet count on mortality in unstable angina/non–ST-segment elevation myocardial infarction

    Page :1214.e1

    Christian Mueller, Franz-Josef Neumann, Willibald Hochholzer, Dietmar Trenk, Thomas Zeller, André P. Perruchoud, Heinz J. Buettner

    Résumé Résumé Plan Plan  
  • ·Virulent strains of Helicobacter pylori and vascular diseases: A meta-analysis

    Page :1215-1222

    Vincenzo Pasceri, Giuseppe Patti, Giovanni Cammarota, Christian Pristipino, Giuseppe Richichi, Germano Di Sciascio

    Résumé Résumé Plan Plan  
  • ·Use of B-type natriuretic peptide in the detection of myocardial ischemia

    Page :1223-1230

    Daniel Staub, Charly Nusbaumer, Michael J. Zellweger, Nils Jonas, Damian Wild, Matthias E. Pfisterer, Jan Mueller-Brand, André P. Perruchoud, Christian Mueller

    Résumé Résumé Plan Plan  
  • ·Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: Analysis from the CADILLAC trial

    Page :1231-1238

    Bruce R. Brodie, Gregg W. Stone, David A. Cox, Thomas D. Stuckey, Mark Turco, James E. Tcheng, Peter Berger, Roxana Mehran, Michael McLaughlin, Costantino Costantini, Alexandra J. Lansky, Cindy L. Grines

    Résumé Résumé Plan Plan  
  • ·The anti-ischemic effect of trimetazidine in patients with postprandial myocardial ischemia is unrelated to meal composition

    Page :1238.e1

    Gabriele Fragasso, Chiara Montano, Gianluca Perseghin, Altin Palloshi, Giliola Calori, Guido Lattuada, Silvia Oggionni, Giorgio Bassanelli, Massimo Locatelli, Gary Lopaschuk, Alberto Margonato

    Résumé Résumé Plan Plan  
  • ·Level of Selvester QRS score is predictive of ST-segment resolution and 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention

    Page :1239.e1

    Huseyin Uyarel, Nese Cam, Ertan Okmen, Hulya Kas?kc?oglu, Zeynep Tartan, Ozgur Akgul, Dilek Simsek, Mustafa Cetin, Emrah Bozbeyoglu, Ali Buturak, Bulent Uzunlar

    Résumé Résumé Plan Plan  
  • ·Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary intervention

    Page :1239.e9

    Peter Elsman, Arnoud W.J. van‘t Hof, Menko-Jan de Boer, Harry Suryapranata, George F. Borm, Jan C.A. Hoorntje, Jan Paul Ottervanger, A.T. Marcel Gosselink, Jan-Henk E. Dambrink, Felix Zijlstra

    Résumé Résumé Plan Plan  
  • ·Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function : Ischemia Management with Accupril post–bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease

    Page :1240-1246

    Wiek H. van Gilst, J. Wayne Warnica, Richard Baillot, David Johnstone, Cristina-Dana Calciu, Pierre Block, Martin G. Myers, Sidney Chocron, Jean-Lucien Rouleau, On behalf of the IMAGINE Investigators

    Résumé Résumé Plan Plan
  • ·Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress–related disease outcomes

    Page :1247.e1

    Duk-Hee Lee, Leo R. Zacharski, David R. Jacobs

    Résumé Résumé Plan Plan  
  • ·Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT—A double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel

    Page :1248-1254

    Helmut Schühlen, Adnan Kastrati, Julinda Mehilli, Jörg Hausleiter, Josef Dirschinger, Franz Dotzer, Hildegard Bollwein, Albert Schömig

    Résumé Résumé Plan Plan  
  • ·Feasibility and benefit of prehospital diagnosis, triage, and therapy by paramedics only in patients who are candidates for primary angioplasty for acute myocardial infarction

    Page :1255.e1

    Arnoud W.J. van 't Hof, Saman Rasoul, Henri van de Wetering, Nicolette Ernst, Harry Suryapranata, Jan C.A. Hoorntje, Jan-Henk E. Dambrink, Marcel Gosselink, Felix Zijlstra, Jan Paul Ottervanger, Menko-Jan de Boer, on behalf of the On-TIME study group a

    Résumé Résumé Plan Plan
  • ·Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction

    Page :1256-1259

    Giuseppe De Luca, Nicolette Ernst, Arnoud W.J. van't Hof, Jan Paul Ottervanger, Jan C.A. Hoorntje, A.T. Marcel Gosselink, Jan-Henk E. Dambrink, Menko-Jan de Boer, Harry Suryapranata

    Résumé Résumé Plan Plan  
  • ·Bare metal stent restenosis is not a benign clinical entity

    Page :1260-1264

    Michael S. Chen, Jim M. John, Derek P. Chew, David S. Lee, Stephen G. Ellis, Deepak L. Bhatt

    Résumé Résumé Plan Plan  
  • ·Preprocedural C-reactive protein levels predict myocardial necrosis after successful coronary stenting in patients with stable angina

    Page :1265-1270

    Alexander Goldberg, Luis Gruberg, Ariel Roguin, Sirouch Petcherski, Drora Rimer, Walter Markiewicz, Rafael Beyar, Doron Aronson

    Résumé Résumé Plan Plan  
  • ·Differences in inhospital mortality between men and women with acute myocardial infarction undergoing percutaneous coronary intervention in Japan: Tokai Acute Myocardial Infarction Study (TAMIS)

    Page :1271-1275

    Yoshihisa Hirakawa, Yuichiro Masuda, Kazumasa Uemura, Masafumi Kuzuya, Takaya Kimata, Akihisa Iguchi

    Résumé Résumé Plan Plan
  • ·Validating the Clinical Outcomes Assessment Program risk model for percutaneous coronary intervention

    Page :1276-1280

    YingXing Wu, Ruyun Jin, Gary L. Grunkemeier

    Résumé Résumé Plan Plan  
  • ·Door-to-drug and door-to-balloon times: Where can we improve? Time to reperfusion therapy in patients with ST-segment elevation myocardial infarction (STEMI)

    Page :1281-1287

    Elizabeth H. Bradley, Jeph Herrin, Yongfei Wang, Robert L. McNamara, Martha J. Radford, David J. Magid, John G. Canto, Martha Blaney, Harlan M. Krumholz

    Résumé Résumé Plan Plan  
  • ·Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarction

    Page :1288-1295

    David E. Kandzari, James E. Tcheng, Bernard J. Gersh, David A. Cox, Thomas Stuckey, Mark Turco, Roxana Mehran, Eulogio Garcia, Peter Zimetbaum, Michael G. McGlaughlin, Alexandra J. Lansky, Costantino O. Costantini, Cindy L. Grines, Gregg W. Stone, for the CADILLAC Investigators

    Résumé Résumé Plan Plan  
  • ·Impact of routine stenting on myocardial perfusion and the extent of myocardial necrosis in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction

    Page :1296.e1

    Giuseppe De Luca, Harry Suryapranata, Arnoud W.J. van't Hof, Jan Paul Ottervanger, Jan C.A. Hoorntje, Jan-Henk Dambrink, A.T. Marcel Gosselink, Menko-Jan de Boer

    Résumé Résumé Plan Plan  
  • ·Effects of peripheral blood stem cell mobilization with granulocyte–colony stimulating factor and their transcoronary transplantation after primary stent implantation for acute myocardial infarction

    Page :1296.e7

    Clemens Steinwender, Robert Hofmann, Jürgen Kammler, Alexander Kypta, Robert Pichler, Wilma Maschek, Gerhard Schuster, Christian Gabriel, Franz Leisch

    Résumé Résumé Plan Plan  
  • ·Excess body weight, clinical profile, management practices, and hospital prognosis in men and women after acute myocardial infarction

    Page :1297-1304

    Robert J. Goldberg, Jiang Cui, Barbara Olendzki, Frederick Spencer, Jorge Yarzebski, Darleen Lessard, Joel Gore

    Résumé Résumé Plan Plan
  • ·Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: Results from the LIPID study

    Page :1305-1312

    Andrew M. Tonkin, Simon Eckermann, Harvey White, Denis Friedlander, Paul Glasziou, Paul Magnus, Adrienne Kirby, Sarah Mulray, Mary Denton, Michele Sallaberger, David Hunt, John Simes, on behalf of the LIPID Study Group

    Résumé Résumé Plan Plan
  • ·The prevalence, nature, and importance of hematologic abnormalities in heart failure

    Page :1313-1321

    Colin Berry, John Norrie, Karen Hogg, Michael Brett, Karen Stevenson, John J.V. McMurray

    Résumé Résumé Plan Plan  
  • ·Life expectancy of elderly and very elderly patients with chronic heart failure

    Page :1322.e1

    Andrew Owen

    Résumé Résumé Plan Plan  
  • ·The influence of short and long duration on the blood pressure response to an acute bout of dynamic exercise

    Page :1322.e5

    Margaux A. Guidry, Bruce E. Blanchard, Paul D. Thompson, Carl M. Maresh, Richard L. Seip, Amy L. Taylor, Linda S. Pescatello

    Résumé Résumé Plan Plan  
  • ·Accuracy of 64-row multidetector computed tomography in detecting coronary artery disease in 134 symptomatic patients: Influence of calcification

    Page :1323.e1

    Tiong Kiam Ong, Sze Piaw Chin, Chee Khoon Liew, Wei Ling Chan, M. Tobias Seyfarth, Houng Bang Liew, Annuar Rapaee, Yean Yip Alan Fong, Choon Kiat Ang, Kui Hian Sim

    Résumé Résumé Plan Plan  
  • ·The impact of hypertension on systolic and diastolic left ventricular function. A tissue Doppler echocardiographic study

    Page :1323.e7

    Manolis Bountioukos, Arend F.L. Schinkel, Jeroen J. Bax, Stylianos Lampropoulos, Don Poldermans

    Résumé Résumé Plan Plan  
  • ·Comparison of exercise echocardiography and the Duke treadmill score for risk stratification in patients with known or suspected coronary artery disease and normal resting electrocardiogram

    Page :1324.e1

    Jesús Peteiro, Lorenzo Monserrrat, Miriam Piñeiro, Ramon Calviño, Jose Manuel Vazquez, Javier Mariñas, Alfonso Castro-Beiras

    Résumé Résumé Plan Plan  
  • ·Effect of exercise training on myocardial blood flow in patients with stable coronary artery disease

    Page :1324.e11

    Keiichiro Yoshinaga, Rob S.B. Beanlands, Robert A. deKemp, Mireille Lortie, Jason Morin, May Aung, Robert McKelvie, Richard F. Davies

    Résumé Résumé Plan Plan  
  • ·Operative and long-term survival of elderly is significantly improved by mitral valve repair

    Page :1325-1333

    Andrew Gogbashian, Jerome Sepic, Edward G. Soltesz, Lugino Nascimben, Lawrence H. Cohn

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Benefits of left atrial appendage occlusion for stroke prevention

    Page :e1

    Claudia Stöllberger, Birke Schneider, Josef Finsterer

    
  • ·Benefits of left atrial appendage occlusion

    Page :e3

    Jeff S. Healey, Sandra Carroll, Stuart J. Connolly, Eugene Crystal

    
  • ·Letter to the Editor

    Page :e5

    Daniel L. Riddle,, Otto D. Payton

    
  • ·Response to Letter to the Editor

    Page :e7

    John A. Spertus, on behalf of the Cardiovascular Outcomes Research Consortium